Investor Rights Agreements in the Pharmaceuticals Industry

143 Contracts & Agreements

Browse by Company

ACHILLION PHARMACEUTICALS INC (1 contract)
Aclaris Therapeutics, Inc. (1)
Aegerion Pharmaceuticals, Inc. (2)
AEON Biopharma, Inc. (2)
AERIE PHARMACEUTICALS INC (2)
ALDER BIOPHARMACEUTICALS INC (2)
ALIMERA SCIENCES INC (2)
Altus Pharmaceuticals Inc. (1)
Amylyx Pharmaceuticals, Inc. (1)
AN2 Therapeutics, Inc. (1)
Anacor Pharmaceuticals, Inc. (1)
Anebulo Pharmaceuticals, Inc. (1)
ANI Pharma Inc (1)
Astex Pharmaceuticals, Inc (1)
Athira Pharma, Inc. (1)
Auspex Pharmaceuticals, Inc. (1)
BioPharmX Corp (2)
Braeburn Pharmaceuticals, Inc. (1)
Cancer Prevention Pharmaceuticals, Inc. (1)
Cara Therapeutics, Inc. (1)
Cerecor Inc. (1)
Charlotte's Web Holdings, Inc. (1)
CHIASMA, INC (1)
CinCor Pharma, Inc. (1)
Clearside Biomedical, Inc. (1)
Clever Leaves Holdings Inc. (1)
COGNITION THERAPEUTICS INC (2)
COLLEGIUM PHARMACEUTICAL, INC (1)
CoLucid Pharmaceuticals, Inc. (1)
Context Therapeutics Inc. (1)
Cyteir Therapeutics, Inc. (1)
DiCE MOLECULES HOLDINGS, LLC (1)
Dova Pharmaceuticals Inc. (1)
Edgewise Therapeutics, Inc. (1)
Eleison Pharmaceuticals Inc (2)
Evofem Biosciences, Inc. (2)
Evoke Pharma Inc (1)
EYENOVIA, INC. (1)
EyePoint Pharmaceuticals, Inc. (1)
EYETECH PHARMACEUTICALS INC (1)
Fulcrum Therapeutics, Inc. (1)
GRAYBUG VISION, INC. (1)
Haymaker Acquisition Corp. III (2)
Horizon Pharma plc (2)
Hoth Therapeutics, Inc. (1)
iANTHUS CAPITAL HOLDINGS, INC. (1)
Ikena Oncology, Inc. (1)
IMARA Inc. (1)
Innoviva, Inc. (1)
Intersect ENT, Inc. (1)
Iterum Therapeutics plc (2)
Jaguar Health, Inc. (2)
Jazz Pharmaceuticals plc (4)
JUNIPER PHARMACEUTICALS INC (1)
Kaleido Biosciences, Inc. (1)
KOLLTAN PHARMACEUTICALS INC (1)
Landos Biopharma, Inc. (2)
Longboard Pharmaceuticals, Inc. (1)
Lumena Pharmaceuticals, Inc. (1)
Lyra Therapeutics, Inc. (3)
MARINUS PHARMACEUTICALS INC (1)
Medicine Man Technologies, Inc. (1)
Menlo Therapeutics Inc. (1)
Molecular Insight Pharmaceuticals, Inc. (1)
MyoKardia Inc (2)
Neos Therapeutics, Inc. (1)
NGM BIOPHARMACEUTICALS INC (1)
OCULAR THERAPEUTIX, INC (1)
OncoMed Pharmaceuticals Inc (1)
OTONOMY, INC. (1)
Pacira Pharmaceuticals, Inc. (1)
Paratek Pharmaceuticals, Inc. (3)
PLAYERS NETWORK (1)
PLIANT THERAPEUTICS, INC. (1)
PLx Pharma Inc. (2)
PRESTWICK PHARMACEUTICALS INC (1)
QUARK PHARMACEUTICALS INC (1)
Ra Pharmaceuticals, Inc. (1)
Rain Therapeutics Inc. (1)
REATA PHARMACEUTICALS INC (1)
Recro Pharma, Inc. (1)
RELMADA THERAPEUTICS, INC. (2)
resTORbio, Inc. (1)
Revance Therapeutics, Inc. (3)
Roivant Sciences Ltd. (2)
Satsuma Pharmaceuticals, Inc. (1)
scPharmaceuticals Inc. (1)
SCYNEXIS INC (1)
Sienna Biopharmaceuticals, Inc. (1)
Supernus Pharmaceuticals, Inc. (2)
Tarsus Pharmaceuticals, Inc. (1)
Terns Pharmaceuticals, Inc. (1)
TETRALOGIC PHARMACEUTICALS CORP (3)
THAR PHARMACEUTICALS INC (1)
Theseus Pharmaceuticals, Inc. (1)
Tilray, Inc. (1)
Trevi Therapeutics, Inc. (1)
Tricida, Inc. (2)
Urovant Sciences Ltd. (1)
Valera Pharmaceuticals Inc (1)
Vallon Pharmaceuticals, Inc. (1)
Ventyx Biosciences, Inc. (1)
Verrica Pharmaceuticals Inc. (1)
VIA Pharmaceuticals, Inc. (1)
Vitae Pharmaceuticals, Inc (1)
Wave Life Sciences Ltd. (2)
XANODYNE PHARMACEUTICALS INC (1)
XCEL PHARMACEUTICALS INC (1)
XERIS PHARMACEUTICALS INC (1)
ZOGENIX, INC. (2)

Recent Contracts

Amendment No. 1 to Ninth Amended and Restated Investor Rights Agreement, dated as of May 25, 2023, by and among Lyra Therapeutics, Inc. and the Investors named therein (Lyra Therapeutics, Inc., Filed With SEC on May 31, 2023)
Investor Rights Agreement dated as of November 21, 2022 (Roivant Sciences Ltd., Filed With SEC on February 13, 2023)
Amendment No. 1 to the Amended and Restated Investors Rights Agreement, dated January 10, 2023, by and between Landos Biopharma, Inc. and the investors that are a party thereto (Landos Biopharma, Inc., Filed With SEC on January 13, 2023)
Investor Rights Agreement, dated November 14, 2022, by and between Charlottes Web Holdings, Inc. and BT DE Investments, Inc. a wholly-owned subsidiary of BAT Group (Charlotte's Web Holdings, Inc., Filed With SEC on November 23, 2022)
Investors Rights Agreement, dated May 20, 2022, by and among Mission Holdings US, Inc., Medicine Man Technologies, Inc., and the Investors party thereto (Medicine Man Technologies, Inc., Filed With SEC on November 10, 2022)
Amended and Restated Investor Rights Agreement, dated as of July 19, 2022, by and among the Company, the Members, the Members Representative, Haymaker Sponsor III LLC and certain... (Haymaker Acquisition Corp. III, Filed With SEC on July 19, 2022)
Investor Rights Agreement dated June 24, 2022 by and among the Company, iAnthus Capital Management, LLC and certain investors (iANTHUS CAPITAL HOLDINGS, INC., Filed With SEC on June 30, 2022)
Investor Rights Agreement, dated as of September 13, 2021, by and among Priovant Holdings, Inc., Roivant Sciences Ltd. and Pfizer Inc (Roivant Sciences Ltd., Filed With SEC on June 28, 2022)
Investor Rights Agreement, dated as of May 26, 2022, by and among the Company, the Members, the Members Representative, Haymaker Sponsor III LLC and certain other parties thereto (Haymaker Acquisition Corp. III, Filed With SEC on June 2, 2022)
Amendment No. 1 to the Investor Rights Agreement, dated May 23, 2022, by and among Innoviva, Inc. and Entasis Therapeutics Holdings Inc (Innoviva, Inc., Filed With SEC on May 24, 2022)
Ninth Amended and Restated Investor Rights Agreement, dated as of April 7, 2022, by and among Lyra Therapeutics, Inc. and the Investors named therein (Lyra Therapeutics, Inc., Filed With SEC on April 13, 2022)
Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated March 5, 2020 (AN2 Therapeutics, Inc., Filed With SEC on March 4, 2022)
Amended and Restated Investor Rights Agreement, dated as of November 13, 2020 (Eleison Pharmaceuticals Inc, Filed With SEC on February 23, 2022)
Amended and Restated Investor Rights Agreement, dated as of November 13, 2020 (Eleison Pharmaceuticals Inc, Filed With SEC on January 24, 2022)
Amended and Restated Investors Rights Agreement, by and among the Registrant and certain of its stockholders, dated September 22, 2021 (CinCor Pharma, Inc., Filed With SEC on December 17, 2021)
Second Amended and Restated Investors Rights Agreement, dated as of July 1, 2021, among the Registrant and the other parties thereto (Amylyx Pharmaceuticals, Inc., Filed With SEC on December 16, 2021)
Amendment No. 1 to Third Amended and Restated Investors Rights Agreement (AEON Biopharma, Inc., Filed With SEC on October 4, 2021)
Amended and Restated Investors Rights Agreement, dated as of September 9, 2021, by and among the Registrant and certain of its Stockholders (Ventyx Biosciences, Inc., Filed With SEC on September 29, 2021)
Third Amended and Restated Investors Rights Agreement, dated April 19, 2017, by and among the Registrant and the investors listed therein (AEON Biopharma, Inc., Filed With SEC on September 17, 2021)
Amended and Restated Investors Rights Agreement, dated January 22, 2021, by and among the Registrant and the other parties thereto (Theseus Pharmaceuticals, Inc., Filed With SEC on September 15, 2021)
Amended and Restated Investors Rights Agreement, dated August 20, 2021, by and among the Registrant and certain of its stockholders (DiCE MOLECULES HOLDINGS, LLC, Filed With SEC on August 27, 2021)
First Amendment dated as of March 23, 2020, to the Third Amended and Restated Investor Rights Agreement dated as March 20, 2014, by and among the Registrant and the investors... (COGNITION THERAPEUTICS INC, Filed With SEC on July 19, 2021)
Third Amended and Restated Investor Rights Agreement dated as of March 20, 2014, by and among the Registrant and the investors listed therein (COGNITION THERAPEUTICS INC, Filed With SEC on July 19, 2021)
Second Amended and Restated Investors Rights Agreement, by and among Cyteir Therapeutics, Inc. and the investors party thereto, dated as of February 5, 2021 (Cyteir Therapeutics, Inc., Filed With SEC on May 28, 2021)
Investors Rights Agreement, dated December 22, 2020, among Context Therapeutics LLC and certain investors (Context Therapeutics Inc., Filed With SEC on May 27, 2021)
Voting and Investor Rights Agreement by and between Alimera Sciences, Inc. and Ocumension Therapeutics, dated as of April 14, 2021 (ALIMERA SCIENCES INC, Filed With SEC on April 14, 2021)
Amended and Restated Investors Rights Agreement, dated September 2, 2020, by and among the Registrant and certain of its stockholders (Rain Therapeutics Inc., Filed With SEC on April 2, 2021)
Investors Rights Agreement, dated June 18, 2020, between Anebulo Pharmaceuticals, Inc. and 22NW, LP (Anebulo Pharmaceuticals, Inc., Filed With SEC on April 1, 2021)
Fourth Amended and Restated Investors Rights Agreement (Ikena Oncology, Inc., Filed With SEC on March 5, 2021)
Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated December 3, 2020 (Edgewise Therapeutics, Inc., Filed With SEC on March 5, 2021)
Investors Rights Agreement by and among the registrant and certain of its stockholders, dated October 27, 2020 (Longboard Pharmaceuticals, Inc., Filed With SEC on February 19, 2021)
Amended and Restated Investors Rights Agreement, dated December 29, 2020, by and among the Registrant and the investors listed therein (Terns Pharmaceuticals, Inc., Filed With SEC on January 15, 2021)
Investors Rights Agreement, dated as of July 25, 2019, by and between Vallon Pharmaceuticals, Inc. and Salmon Pharma GmbH (Vallon Pharmaceuticals, Inc., Filed With SEC on January 14, 2021)
Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated August 9, 2019 (Landos Biopharma, Inc., Filed With SEC on January 13, 2021)
Voting and Investor Rights Agreement, dated December 31, 2020, by and among EyePoint Pharmaceuticals, Inc., Ocumension Therapeutics, and EW Healthcare Partners, L.P. and EW... (EyePoint Pharmaceuticals, Inc., Filed With SEC on January 4, 2021)
Investors Rights Agreement, dated as of December 18, 2020, among Clever Leaves Holdings Inc. and certain shareholders named therein (Clever Leaves Holdings Inc., Filed With SEC on December 28, 2020)
Amended and Restated Investors Rights Agreement, dated September 24, 2020, by and among the Registrant and the other parties thereto (Tarsus Pharmaceuticals, Inc., Filed With SEC on October 9, 2020)
Investors Rights Agreement, dated May 29, 2020, as amended, by and among the Registrant and the Investors and Key Holders party thereto (Athira Pharma, Inc., Filed With SEC on September 9, 2020)
Amended and Restated Investors Rights Agreement, dated July 31, 2019, by and among the Registrant and certain of its stockholders (GRAYBUG VISION, INC., Filed With SEC on September 4, 2020)
Amended and Restated Investors Rights Agreement by and among the Registrant and certain of its stockholders, dated December 19, 2019 (PLIANT THERAPEUTICS, INC., Filed With SEC on May 11, 2020)